(Q44935647)

7 December 2017

title

Effect of high-dose intravenous eletriptan on coronary artery diameter (English)

1 reference

7 December 2017

1 reference

Goldstein JA

1

1 reference

7 December 2017

Massey KD

2

1 reference

7 December 2017

Kirby S

3

1 reference

7 December 2017

Gibson M

4

1 reference

7 December 2017

Hettiarachchi J

5

1 reference

7 December 2017

Rankin AJ

6

1 reference

7 December 2017

Jackson NC

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

24

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

515-521

1 reference

Migraine--current understanding and treatment

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Adverse reactions attributed to sumatriptan. A postmarketing study in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Coronary side-effect potential of current and prospective antimigraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Is chest pain after sumatriptan oesophageal in origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Exercise testing in patients with chest pain to sumatriptan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

The haemodynamic effects of subcutaneous sumatriptan, a 5HT1-receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

Coronary vasoconstriction induced by mental stress (simulated public speaking).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2003.00713.X

10.1111/J.1468-2982.2003.00713.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference